To evaluate combination therapy in vivo, we developed a unique ERBB2+ BC orthotopic nude mouse model of spontaneous metastasis that showed primary tumor growth and clinically relevant distant metastasis to brain, bone, liver, and lung. The gene discussed is ERBB2; the disease is breast cancer.